Department of Radiation Oncology, DMCH Cancer Care Center, Ludhiana, Punjab, India.
Department of Radiation Oncology, Fortis Cancer Institute, Fortis Hospital, Mohali, Punjab, India.
Asian Pac J Cancer Prev. 2022 Jul 1;23(7):2407-2413. doi: 10.31557/APJCP.2022.23.7.2407.
The standard treatment for cervical cancer is chemoradiation therapy. Pelvic radiation is associated with higher dose to bone marrow (BM) causing interrupted treatment due to haematologic toxicity with inferior outcomes. This study aims to evaluate rapid arc technique in sparing pelvic BM and dosimetric parameters for pelvis V5GY, V10GY, V20GY, V30GY, and V40GY dose.
Twenty one cervical cancer patients were selected for the analysis. Planning target volume (PTV) contours, total pelvic BM and surrounding structures contours were standardised. Two rapid arc based procedures were designed for individual patient. One was done using bone marrow sparing (BMS) constraints while other was performed without BMS constraints. Data for both plans was calculated with regard to PTV, normal structures and pelvic BM. Difference in dose distribution in both groups was analysed using Wilcoxon and Friedman ANOVA test.
In the presence of BM constraint a significant changes in pelvic BM dose for values of V10GY (p=0.002), V20GY (p=0.002) and V40GY (p=0.025) was observed. The coverage of PTV was found to be unaffected by adding BM constraint.
The BM is radiosensitive structure so dosage is linked with haemtological toxicity. Increased dose is associated with higher grade of haematological toxicity in pelvic radiotherapy. The study suggests that adding BM constraint in plans reduced the pelvic BM dose while not affecting PTV coverage and dose to bowel, bladder and rectum. Bone marrow constraint in pelvic radiotherapy can be considered for better treatment toleration and to determine its role in decreasing haematological toxicity.
宫颈癌的标准治疗方法是放化疗。盆腔放疗会导致骨髓(BM)受到更高剂量的辐射,从而因血液毒性而中断治疗,导致治疗效果不佳。本研究旨在评估弧形调强放疗技术在保护盆腔骨髓和评估骨盆 V5GY、V10GY、V20GY、V30GY 和 V40GY 剂量的剂量学参数方面的作用。
选择 21 例宫颈癌患者进行分析。对计划靶区(PTV)轮廓、全盆腔 BM 和周围结构轮廓进行标准化。为每位患者设计了两种基于快速弧形的方案。一种方案采用骨髓保护(BMS)约束,另一种方案不采用 BMS 约束。分别计算两种方案的 PTV、正常结构和盆腔 BM 的数据。采用 Wilcoxon 和 Friedman ANOVA 检验分析两组之间的剂量分布差异。
在存在 BM 约束的情况下,V10GY(p=0.002)、V20GY(p=0.002)和 V40GY(p=0.025)的盆腔 BM 剂量发生了显著变化。添加 BM 约束后,PTV 的覆盖范围未受影响。
骨髓是辐射敏感结构,因此剂量与血液毒性有关。盆腔放疗中剂量增加与血液毒性程度增加相关。该研究表明,在计划中添加 BM 约束可以降低盆腔 BM 剂量,同时不影响 PTV 覆盖范围以及对肠道、膀胱和直肠的剂量。在盆腔放疗中,可以考虑采用 BM 约束来提高治疗耐受性,并确定其在降低血液毒性方面的作用。